Table 4 |
||||||||||
|
Association of C/T polymorphism of the GDF5 gene with CDH when stratified by severity |
||||||||||
|
Groups compared |
TT vs. other combined |
CC vs. other combined |
T allele vs. C allele |
All genotype |
||||||
|
|
|
|
|
|||||||
|
OR |
P value |
95% CI |
OR |
P value |
95% CI |
OR |
P value |
95% CI |
P value |
|
|
|
||||||||||
|
Patients with hip dislocation (n = 264) vs all controls (n = 622) |
1.41 |
0.023 |
1.05 to 1.89 |
0.49 |
0.044 |
0.24 to 0.99 |
1.40 |
0.0078 |
1.09 to 1.79 |
0.028 |
|
Patients with hip subluxation (n = 53) vs all controls (n = 622) |
1.35 |
0.31 |
0.76 to 2.41 |
0.49 |
0.32 |
0.12 to 2.08 |
1.36 |
0.22 |
0.83 to 2.20 |
0.46 |
|
Patients with hip instability (n = 21) vs all controls (n = 622) |
1.64 |
0.29 |
0.65 to 4.11 |
0.63 |
0.65 |
0.08 to 4.77 |
1.51 |
0.30 |
0.69 to 3.29 |
0.57 |
|
|
||||||||||
|
CDH = congenital dysplasia of the hip; CI = confidence interval; GDF5 = growth differentiate factor 5; OR = odds ratio. |
||||||||||
|
Dai et al. Arthritis Research & Therapy 2008 10:R126 doi:10.1186/ar2540 |
||||||||||